Medicine recalls
|
| |
| The United States: Insight Pharmaceuticals issues voluntary nationwide recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid due to the presence of Benzene |
| |
The US Food and Drug Administration (FDA) announces that Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company ("Insight"), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid (lot number: 0H50545, 1G50645) to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredient in any Ting® Antifungal Spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid (either before or after these batch codes) and no other Ting® Antifungal Spray Liquid products are in the scope of this recall and may continue to be used by consumers safely and as intended.
Samples of the recalled lots have been found to contain elevated levels of Benzene related to the propellant that sprays the product out of the can. Benzene is not an ingredient in any Ting products. The affected TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid lots were distributed nationwide in the United States through a limited number of retailers and online.
Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it potentially can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life threatening. Insight is recalling these products out of an abundance of caution. To date, the Company has not received any serious adverse events related to this recall.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/insight-pharmaceuticals-issues-voluntary-nationwide-recall-tingr-1-tolnaftate-athletes-foot-spray
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, Feb 3, 2024
Issued at HKT 12:00
|
| |
